Stocks and Investing
Stocks and Investing
Tue, March 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Neil Mehta Maintained (APA) at Strong Sell with Decreased Target to $31 on, Mar 26th, 2024
Neil Mehta of Goldman Sachs, Maintained "APA Corporation" (APA) at Strong Sell with Decreased Target from $35 to $31 on, Mar 26th, 2024.
Neil has made no other calls on APA in the last 4 months.
There are 8 other peers that have a rating on APA. Out of the 8 peers that are also analyzing APA, 4 agree with Neil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mark Lear of "Piper Sandler" Maintained at Hold with Decreased Target to $33 on, Thursday, March 7th, 2024
- Paul Cheng of "Scotiabank" Downgraded from Buy to Hold and Decreased Target to $37 on, Tuesday, January 16th, 2024
- Charles Meade of "Johnson Rice" Downgraded from Strong Buy to Hold and Held Target at $40 on, Friday, January 5th, 2024
- Josh Silverstein of "UBS" Maintained at Hold with Decreased Target to $41 on, Thursday, December 14th, 2023
These are the ratings of the 4 analyists that currently disagree with Neil
- Neal Dingmann of "Truist Securities" Reiterated at Strong Buy and Held Target at $59 on, Wednesday, March 20th, 2024
- William Janela of "Mizuho" Maintained at Sell with Decreased Target to $34 on, Friday, March 15th, 2024
- Biju Perincheril of "Susquehanna" Maintained at Buy with Decreased Target to $50 on, Friday, January 26th, 2024
- John Freeman of "Raymond James" Maintained at Strong Buy with Decreased Target to $43 on, Wednesday, January 24th, 2024
Contributing Sources